Eli Lilly’s trial weight-loss drug reduces heart failure risk by 38%
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,.
Drugs
Health
Pharma
Health
Medical
Dim lights hours before sleep to avoid gestational diabetes mellitus
Exposure to bright lights before sleep can induce gestational diabetes mellitus in pregnant women, a study by Northwestern Medicine, an affiliate of Northwestern.
Drugs
Medical
Pharma
Merck says trial hypertension drug enhances patients’ walk time
Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.